article_metadata: Katsuo Usuda Yo Niida Shun Iwai Aika Funasaki Atsushi Sekimura Nozomu Motono Sohsuke Yamada Hidetaka Uramoto
article_metadata: 10.3389/fonc.2020.00689
article_metadata: Front Oncol
article_metadata: 2020 Jun 2;10:689.
article_metadata: immune checkpoint inhibitor (ici) lung cancer microsatellite instability (msi) programmed death ligand 1 (pd-l1) tumor mutation burden (tmb)
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/32582526/
article_metadata: Case Reports
article_metadata: PMC7280536
article_metadata: 32582526
article_metadata: Higher Tumor Mutation Burden and Higher PD-L1 Activity Predicts the Efficacy of Immune Checkpoint Inhibitor Treatment in a Patient With Four Lung Cancers. A Case Report
article_metadata: 2020